Carcinoma in situ of skin of right eyelid, including canthus
ICD-10 D04.11 is a billable code used to indicate a diagnosis of carcinoma in situ of skin of right eyelid, including canthus.
Carcinoma in situ of the skin of the right eyelid, including the canthus, is a localized form of skin cancer characterized by the presence of abnormal cells that have not invaded deeper tissues. This condition is often associated with sun exposure and can manifest as a scaly patch, a raised bump, or a sore that does not heal. The eyelid is a particularly sensitive area, and lesions here can affect vision and cosmetic appearance. Diagnosis typically involves a biopsy, which confirms the presence of atypical keratinocytes confined to the epidermis. Treatment options may include surgical excision, cryotherapy, or topical chemotherapy, depending on the size and characteristics of the lesion. Regular follow-up is essential to monitor for recurrence or the development of new lesions, as patients with carcinoma in situ are at increased risk for subsequent skin cancers.
Detailed clinical notes including lesion size, location, and treatment plan.
Diagnosis and treatment of skin lesions, follow-up for skin cancer surveillance.
Ensure accurate documentation of the biopsy results and treatment modalities.
Documentation of any impact on vision and coordination with dermatology for treatment.
Management of eyelid lesions affecting vision or requiring surgical intervention.
Consideration of cosmetic outcomes and functional implications of eyelid surgery.
Used when excising a carcinoma in situ lesion from the eyelid.
Document the size and location of the lesion, along with the excision details.
Ensure coordination between dermatology and ophthalmology for eyelid lesions.
Accurate coding of D04.11 is crucial for appropriate treatment planning, reimbursement, and tracking of skin cancer incidence. It ensures that patients receive the necessary follow-up care and surveillance for potential progression.
